Rony Kapoor
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.
Journal: Journal for immunotherapy of cancer
Published: March 10, 2025
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
Journal: The New England journal of medicine
Published: June 03, 2024
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 11, 2024
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial.
Journal: Nature medicine
Published: March 04, 2024
FDG-PET to predict long-term outcome from anti-PD-1 therapy in metastatic melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 29, 2021
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 21, 2021
Risk of radiation necrosis after stereotactic radiosurgery for melanoma brain metastasis by anatomical location.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: November 30, 2020
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial.
Journal: The Lancet. Oncology
Published: February 24, 2019
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies.
Journal: Pigment cell & melanoma research
Published: September 11, 2018
FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 24, 2018
Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 14, 2017
Recurrent bowel obstruction: unusual presentation of pembrolizumab-induced pancreatitis in annular pancreas.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 23, 2017
Last Updated: 09/26/2026